← Back to Clinical Trials
Recruiting NCT05797909

NCT05797909 The PCOS Challenge Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05797909
Status Recruiting
Phase
Sponsor PCOS Challenge: The National Polycystic Ovary Syndrome Association
Condition Polycystic Ovary Syndrome
Study Type OBSERVATIONAL
Enrollment 15,000 participants
Start Date 2022-06-22
Primary Completion 2042-06

Eligibility & Interventions

Sex Female only
Min Age 12 Years
Max Age 80 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 15,000 participants in total. It began in 2022-06-22 with a primary completion date of 2042-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The primary purpose of The PCOS Challenge Study will be to conduct high-quality research where patients are included in the design, and answering the questions that patients identify as important to their lived experience with PCOS. In partnership with clinical investigators, patients will work on the development and management of data collection, the research agenda, and the sharing of research findings. The PCOSC Study will promote the advancement of research that provides reliable, useful, and meaningful information to patients with PCOS and their clinicians. The population for The PCOS Challenge Study will include individuals with a clinical diagnosis of PCOS, individuals self-diagnosed with PCOS, individuals with symptoms of PCOS (e.g., hirsutism, irregular menstrual cycles), and demographic-matched controls without PCOS.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with PCOS by a health professional, self-diagnosed with PCOS or individuals with PCOS symptoms * Willing to sign the consent form * Able to understand the registry surveys or what is being asked Exclusion Criteria: * Unable to understand the surveys or what is being asked * Unwilling to sign the consent form

Contact & Investigator

Central Contact

Sasha Ottey, MHA, MT (ASCP)

✉ info@pcoschallenge.org

📞 (404) 855-7244

Principal Investigator

Sasha Ottey, MHA, MT (ASCP)

PRINCIPAL INVESTIGATOR

PCOS Challenge: The National Polycystic Ovary Syndrome Association

Frequently Asked Questions

Who can join the NCT05797909 clinical trial?

This trial is open to female participants only, aged 12 Years or older, up to 80 Years, studying Polycystic Ovary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05797909 currently recruiting?

Yes, NCT05797909 is actively recruiting participants. Contact the research team at info@pcoschallenge.org for enrollment information.

Where is the NCT05797909 trial being conducted?

This trial is being conducted at Bethesda, United States.

Who is sponsoring the NCT05797909 clinical trial?

NCT05797909 is sponsored by PCOS Challenge: The National Polycystic Ovary Syndrome Association. The principal investigator is Sasha Ottey, MHA, MT (ASCP) at PCOS Challenge: The National Polycystic Ovary Syndrome Association. The trial plans to enroll 15,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology